clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
Topics
New Blood Test Predicts Risk for COPD and Severe Respiratory Diseases
Topics
Burn Rubber: Superluminal Medicines Gets $120M to Take GPCR Drugs to…
Topics
Age-Related Changes in Fibroblasts Drive Treatment-Resistant Melanoma in Males
Topics
Gene Therapy for Inherited Retinal Dystrophy Shows Promise
Topics
More Evidence Diabetes Increases Risk of Sudden Death
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Home
Topics
Page 690
Topics
News & Features
ARUP Partners with PierianDx to Produce Diagnostic Genetic Tests
Inside Precision Medicine Staff Writer
-
November 13, 2014
0
Molecular Dx
The Promise and Challenge of Molecular Diagnostics
Jonathan Frampton, Ph.D.
-
November 5, 2014
0
Informatics
Community Organizing Meets the Clinic
Alex Philippidis
-
November 5, 2014
0
News & Features
Traversing the Cancer Biomarker Labyrinth
Kathy Liszewski
-
November 5, 2014
0
News & Features
Roche Plans $467M Diagnostics Manufacturing Facility in China
Inside Precision Medicine Staff Writer
-
November 5, 2014
0
News & Features
Exceptional Responders: The “N of 1” Paradigm
Patricia Fitzpatrick Dimond, Ph.D.
-
November 5, 2014
0
News & Features
First U.K. Molecular Medicine Center to Benefit NHS Cancer Patients Established
Inside Precision Medicine Staff Writer
-
October 23, 2014
0
News & Features
Akers Biosciences Enters JV to Market Rapid Diagnostic Tests in China
Inside Precision Medicine Staff Writer
-
October 23, 2014
0
Molecular Dx
Next-Generation Sequencing at the Heart of Personalized Cancer Treatment
Chris Anderson
-
October 22, 2014
0
Molecular Dx
Challenges Remain in MS-based Proteomic Analysis of Complex Biological Samples
Patricia Fitzpatrick Dimond, Ph.D.
-
October 22, 2014
0
1
...
689
690
691
...
702
Page 690 of 702
Related Content
Leapfrog Bio Screens Clinical Stage Drugs to Jump into Cancer Markets
A Pill for That: Biora’s Innovative Pills Aim to Optimize Drug Delivery
IL-6 Levels Predict Cancer Risk in People with Type 2 Diabetes
BiomeSense to Test Microbiome GutLab Technology with Pendulum
Inside Precision Medicine
![One of the major roadblocks to successful biomarker development is an inadequate specimen procurement process. [Science Photo/Fotolia]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/148.jpeg "Traversing the Cancer Biomarker Labyrinth")
![The NCI is funding research to determine whether outliers from failed clinical trials can reveal hidden drug development possibilities. [iStock/francisblack]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/147.jpeg "Exceptional Responders: The “N of 1” Paradigm")
![The power of new sequencing technologies is their ability to unlock information about the variable nature of solid tumors to provide clinicians with a better understanding of cancer’s mechanisms. [© Monika Wisniewska/Fotolia]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/138.jpeg "Next-Generation Sequencing at the Heart of Personalized Cancer Treatment")
![One novel technique for capturing clinically important low-abundance proteins is to create core-shell hydrogel nanoparticles containing high affinity reactive chemical baits for protein and peptide harvesting and concentration. [AlexRaths/iStock Photos]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/139.jpeg "Challenges Remain in MS-based Proteomic Analysis of Complex Biological Samples")
